Sequestration of drugs in the circuit may lead to therapeutic failure during extracorporeal membrane oxygenation

scientific article published on 15 October 2012

Sequestration of drugs in the circuit may lead to therapeutic failure during extracorporeal membrane oxygenation is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1186/CC11679
P932PMC publication ID3682296
P698PubMed publication ID23068416
P5875ResearchGate publication ID232254689

P50authorMaree SmithQ24851696
Jason A. RobertsQ38544404
Adrian G. BarnettQ38590672
Yoke Lin FungQ50648552
Kiran ShekarQ58396529
Steven C WallisQ58397119
P2093author name stringJohn F Fraser
Daniel V Mullany
Sussan Ghassabian
Charles I Mcdonald
Stephanie Fisquet
P2860cites workPharmacokinetic changes during extracorporeal membrane oxygenation: implications for drug therapy of neonatesQ30310834
Contemporary extracorporeal membrane oxygenation for adult respiratory failure: life support in the new era.Q30410342
Antibiotic dosing in the 'at risk' critically ill patient: Linking pathophysiology with pharmacokinetics/pharmacodynamics in sepsis and trauma patientsQ33824276
Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patientsQ34052619
Pharmacokinetics in the newbornQ35111481
Pharmacokinetics of vancomycin in critically ill infants undergoing extracorporeal membrane oxygenation.Q35124226
Population pharmacokinetics of vancomycin in patients receiving extracorporeal membrane oxygenationQ35826801
Antibiotic resistance--what's dosing got to do with it?Q37205795
Pharmacokinetic issues for antibiotics in the critically ill patientQ37399820
Pharmacokinetics and pharmacodynamics in critically ill patientsQ37758059
Antibiotic dosing in multiple organ dysfunction syndromeQ37871704
Sedation and analgesia in the mechanically ventilated patientQ37948029
Pharmacokinetic changes in patients receiving extracorporeal membrane oxygenationQ38004165
Increased sedation requirements in patients receiving extracorporeal membrane oxygenation for respiratory and cardiorespiratory failureQ38027639
Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patientsQ39487652
Determinants of drug absorption in different ECMO circuits.Q42362818
Population pharmacokinetics of midazolam and its metabolites during venoarterial extracorporeal membrane oxygenation in neonates.Q43060269
Stability of meropenem and doripenem solutions for administration by continuous infusionQ43153667
Sedative clearance during extracorporeal membrane oxygenationQ46857795
Development of simulated and ovine models of extracorporeal life support to improve understanding of circuit-host interactions.Q47623151
Sedation during extracorporeal membrane oxygenation-why more is lessQ48111467
High-throughput assay for simultaneous quantification of the plasma concentrations of morphine, fentanyl, midazolam and their major metabolites using automated SPE coupled to LC-MS/MS.Q48142980
In vitro evaluation of sedative drug losses during extracorporeal membrane oxygenation.Q51417979
Morphine metabolite pharmacokinetics during venoarterial extra corporeal membrane oxygenation in neonates.Q51938979
Altered antibiotic pharmacokinetics during extracorporeal membrane oxygenation: cause for concern?Q58812745
Do we understand the impact of altered physiology, consequent interventions and resultant clinical scenarios in the intensive care unit? The antibiotic storyQ64129476
Preliminary studies of the effects of extracorporeal membrane oxygenator on the disposition of common pediatric drugsQ72595886
Potential drug sequestration during extracorporeal membrane oxygenation: results from an ex vivo experimentQ80089048
Current status of extracorporeal life support (ECMO) for cardiopulmonary failureQ84543309
P433issue5
P921main subjectextracorporeal membrane oxygenationQ1385195
P304page(s)R194
P577publication date2012-10-15
P1433published inCritical CareQ5186602
P1476titleSequestration of drugs in the circuit may lead to therapeutic failure during extracorporeal membrane oxygenation
P478volume16